India participates in WHO meeting on global herbal pharmacopoeia

India, represented by PCIM&H, participated in the 5th WHO Expert Meeting on International Herbal Pharmacopoeia. This meeting focused on advancing global standards for herbal medicines and took place recently under WHO's initiative to promote traditional medicine worldwide. The event highlights India's commitment to contributing to global health standards.

The Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) is a key institution under the Ministry of AYUSH, responsible for setting standards for Indian traditional medicines. By participating in this WHO meeting, India aims to strengthen its role in shaping international guidelines for herbal pharmacopoeia, ensuring quality and safety in herbal medicine practices globally.

WHO's International Herbal Pharmacopoeia initiative seeks to harmonize standards for herbal medicines, which are widely used in traditional healthcare systems across the world. India's involvement underscores its leadership in the field of Ayurveda and other indigenous systems of medicine.

This collaboration also aligns with India's broader efforts to integrate traditional medicine into global healthcare frameworks. It reflects the country's ongoing support for WHO's mission to enhance the credibility and scientific validation of herbal medicines, benefiting millions worldwide.

Key Points
- India participated in the 5th WHO Expert Meeting on Herbal Pharmacopoeia.
- PCIM&H represented India in the meeting.
- The event focused on global standards for herbal medicines.
- WHO aims to harmonize herbal medicine practices worldwide.
- India supports WHO's efforts to validate traditional medicine scientifically.

FAQ

What was the focus of the WHO meeting India attended?
The meeting focused on advancing global standards for herbal medicines.